Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives
International Journal of Molecular Sciences · 06.06.2025 · 26 (12) · 5439
DOI: 10.3390/ijms26125439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.06.2025. Verfasst von Mario Caldarelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Inflammasomes, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic inflammation is an important contributor to the development of cardiovascular disorders, and inflammasomes, especially the NOD-like receptor protein 3 (NLRP3), are emerging as crucial mediators in this context. Inflammasomes are activated through receptor-mediated danger signals, such as cholesterol crystals and cellular damage products, thereby stimulating the secretion of pro-inflammatory cytokines, which sustains inflammation. This mechanism drives atherosclerosis (via plaque formation and destabilization), heart failure (via fibrotic remodeling), and pericarditis (via exacerbation of pericardial inflammation). Therapeutic approaches seek to block inflammasome activation or their pro-inflammatory pathways. Colchicine, interleukin-1 inhibitors (anakinra, canakinumab), and Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors have a positive impact on cardiovascular inflammation. Various new compounds, such as MCC950, have been described as novel specific inhibitors of NLRP3. Further studies are needed to validate the effectiveness and safety of these treatments. Further elucidating the role of inflammasomes in cardiovascular disease could open the way to achieving more effective therapies, allowing for better management of high-risk cardiovascular patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli-IRCCS of Rome, 00168 Rome, Italy.
- Emergency Department, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy.
ORCID-Profile: Mario Caldarelli, Laura Franza, Antonio Gasbarrini, Rossella Cianci
Zitieren
APA
Caldarelli, M., Franza, L., Cutrupi, S., Menegolo, M., Franceschi, F., Gasbarrini, A., Gambassi, G., & Cianci, R. (2025). Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives. International Journal of Molecular Sciences, 26(12), 5439. https://doi.org/10.3390/ijms26125439
Vancouver
Caldarelli M, Franza L, Cutrupi S, Menegolo M, Franceschi F, Gasbarrini A, et al. Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives. International Journal of Molecular Sciences. 2025;26(12):5439. doi:10.3390/ijms26125439
BibTeX
@article{Caldarelli2025,
author = {Caldarelli, Mario and Franza, Laura and Cutrupi, Sebastiano and Menegolo, Martina and Franceschi, Francesco and Gasbarrini, Antonio and Gambassi, Giovanni and Cianci, Rossella},
title = {Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5439},
doi = {10.3390/ijms26125439}
}
EUVIMED